ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cresset Biomolecular Discovery Limited

Cresset Biomolecular Discovery Limited is an active company incorporated on 31 January 2001 with the registered office located in Royston, Cambridgeshire. Cresset Biomolecular Discovery Limited was registered 24 years ago.
Status
Active
Active since 22 years ago
Company No
04151475
Private limited company
Age
24 years
Incorporated 31 January 2001
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Confirmation
Submitted
Dated 30 September 2024 (11 months ago)
Next confirmation dated 30 September 2025
Due by 14 October 2025 (1 month remaining)
Last change occurred 10 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Group
Next accounts for period 31 March 2025
Due by 31 December 2025 (3 months remaining)
Contact
Address
New Cambridge House
Bassingbourn Road
Litlington
Cambridgeshire
SG8 0SS
Same address for the past 12 years
Telephone
01223858890
Email
Available in Endole App
People
Officers
9
Shareholders
19
Controllers (PSC)
1
Secretary • Director • Director And Company Secretary • British • Lives in UK • Born in Sep 1974
Director • British • Lives in England • Born in Aug 1966
Director • British • Lives in England • Born in Jun 1988
Director • British • Lives in UK • Born in Jan 1966
Director • British • Lives in UK • Born in Jan 1971
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Torx Software Ltd
Dr Timothy John Cheeseright, Dr Robert Arthur Scoffin, and 1 more are mutual people.
Active
Cam Boathouse Company Limited(The)
Mr John Perrot Leighton is a mutual person.
Active
SPT Labtech Limited
David Allan Newble is a mutual person.
Active
Fluidic Sciences Limited
David Allan Newble is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
£2.56M
Decreased by £5.52M (-68%)
Turnover
£6.77M
Increased by £6.77M (%)
Employees
115
Increased by 48 (+72%)
Total Assets
£8.33M
Decreased by £4.96M (-37%)
Total Liabilities
-£4.08M
Decreased by £1.15M (-22%)
Net Assets
£4.25M
Decreased by £3.8M (-47%)
Debt Ratio (%)
49%
Increased by 9.6% (+24%)
Latest Activity
Group Accounts Submitted
5 Months Ago on 2 Apr 2025
Dr Robert Arthur Scoffin Details Changed
9 Months Ago on 26 Nov 2024
Dr Timothy John Cheeseright Details Changed
9 Months Ago on 26 Nov 2024
Chief Scientific Officer Mark Denis Mackey Details Changed
9 Months Ago on 20 Nov 2024
Confirmation Submitted
10 Months Ago on 14 Oct 2024
David William Bardsley Resigned
1 Year 3 Months Ago on 14 May 2024
Dale Curtis Jr Appointed
1 Year 4 Months Ago on 1 May 2024
Full Accounts Submitted
1 Year 8 Months Ago on 5 Jan 2024
Confirmation Submitted
1 Year 11 Months Ago on 2 Oct 2023
Mr John Perrot Leighton Appointed
2 Years 5 Months Ago on 11 Apr 2023
Get Credit Report
Discover Cresset Biomolecular Discovery Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Resolutions
Submitted on 21 Aug 2025
Memorandum and Articles of Association
Submitted on 21 Aug 2025
Statement of capital following an allotment of shares on 21 August 2025
Submitted on 21 Aug 2025
Statement of capital following an allotment of shares on 14 August 2025
Submitted on 19 Aug 2025
Statement of capital following an allotment of shares on 12 May 2025
Submitted on 12 May 2025
Group of companies' accounts made up to 31 March 2024
Submitted on 2 Apr 2025
Statement of capital following an allotment of shares on 31 March 2025
Submitted on 31 Mar 2025
Statement of capital following an allotment of shares on 8 January 2025
Submitted on 9 Jan 2025
Second filing of a statement of capital following an allotment of shares on 23 December 2024
Submitted on 8 Jan 2025
Statement of capital following an allotment of shares on 13 December 2024
Submitted on 7 Jan 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year